William Blair Investment Management LLC Takes Position in Humana Inc. $HUM

Key Points

• William Blair Investment Management purchased 34,161 Humana shares during the second quarter, valued at approximately $13.6 million. Institutional investors now own 92.38% of the company.
• Analyst sentiment is mixed, with a consensus rating of “Hold” from 30 analysts and an average price target of $395.22; price targets range from $195 to $502.
• Humana exceeded quarterly expectations, reporting $7.61 in earnings per share versus the $7.27 consensus and $40.89 billion in revenue, up 26.2% year over year.

William Blair Investment Management LLC purchased a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 34,161 shares of the insurance provider's stock, valued at approximately $13,569,000.

Other institutional investors also recently bought and sold shares of the company. Korea Investment CORP purchased a new position in Humana during the second quarter worth $34,579,000. EP Wealth Advisors LLC bought a new stake in shares of Humana in the 2nd quarter worth about $276,000. Ieq Capital LLC bought a new stake in shares of Humana in the 2nd quarter worth about $3,502,000. Callan Family Office LLC purchased a new position in shares of Humana during the 2nd quarter worth about $538,000. Finally, Heartland Advisors Inc. purchased a new position in shares of Humana during the 2nd quarter worth about $11,770,000. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of recent analyst reports. TD Cowen increased their price objective on shares of Humana from $350.00 to $370.00 and gave the stock a "hold" rating in a research report on Friday, July 31st. The Goldman Sachs Group boosted their target price on Humana from $158.00 to $195.00 and gave the company a "sell" rating in a research report on Thursday, April 30th. Wells Fargo & Company upgraded Humana from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $227.00 to $502.00 in a report on Monday, July 13th. Jefferies Financial Group raised Humana from a "buy" rating to a "buy" rating in a research note on Wednesday, May 20th. Finally, JPMorgan Chase & Co. boosted their price objective on Humana from $316.00 to $393.00 and gave the company a "neutral" rating in a report on Monday, August 10th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $395.22.

Humana Trading Down 0.4%

Shares of HUM opened at $379.22 on Friday. The firm has a market capitalization of $45.54 billion, a price-to-earnings ratio of 35.88, a PEG ratio of 2.17 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88. The company has a 50-day moving average of $383.38 and a 200 day moving average of $281.59.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. The business had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company's revenue for the quarter was up 26.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.27 EPS. On average, research analysts expect that Humana Inc. will post 9.08 EPS for the current year.

Humana Company Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source